SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001047469-18-007059
Filing Date
2018-11-06
Accepted
2018-11-05 20:08:38
Documents
15
Effectiveness Date
2018-11-06

Document Format Files

Seq Description Document Type Size
1 DEFM14A a2237055zdefm14a.htm DEFM14A 8028216
2 G189282MMI001.GIF g189282mmi001.gif GRAPHIC 74471
3 G189282MMI002.GIF g189282mmi002.gif GRAPHIC 37588
4 G352623.JPG g352623.jpg GRAPHIC 15335
5 G682455.JPG g682455.jpg GRAPHIC 21333
6 G713610.JPG g713610.jpg GRAPHIC 17535
7 G742642.JPG g742642.jpg GRAPHIC 35385
8 G919280.JPG g919280.jpg GRAPHIC 46087
9 G900054.JPG g900054.jpg GRAPHIC 54985
10 G38999.JPG g38999.jpg GRAPHIC 49968
11 G21417.JPG g21417.jpg GRAPHIC 91856
12 G757576.JPG g757576.jpg GRAPHIC 32032
13 G240336.JPG g240336.jpg GRAPHIC 27828
14 G472631.JPG g472631.jpg GRAPHIC 16408
15 G816323.JPG g816323.jpg GRAPHIC 11064
  Complete submission text file 0001047469-18-007059.txt   8763700
Mailing Address 9 FOURTH AVE WALTHAM MA 02451
Business Address 9 FOURTH AVE WALTHAM MA 02451 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35890 | Film No.: 181161247
SIC: 2834 Pharmaceutical Preparations